Monro, Inc. (MNRO) director receives 11,149-share restricted stock grant
Rhea-AI Filing Summary
Okray Thomas B reported acquisition or exercise transactions in this Form 4 filing.
Monro, Inc. director Thomas B. Okray reported an award of 11,149 shares of common stock on August 11, 2026. The award is in the form of restricted stock granted under the company’s Amended and Restated 2007 Stock Incentive Plan and carries no cash purchase price. Following this grant, Okray’s direct holdings total 24,392 shares. The restricted stock vests in three equal installments, one-third on each of the first three anniversaries of the grant date.
Positive
- None.
Negative
- None.
Insider Trade Summary
Net Buyer: 11,149 shares
Net Buy
1 txn
Insider
Okray Thomas B
Role
Director
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Common Stock F1 | 11,149 | $0.00 | $0.00 |
Holdings After Transaction:
Common Stock — 24,392 shares (Direct)
Footnotes (1)
- F1. This award of restricted stock is granted under the Company's Amended and Restated 2007 Stock Incentive Plan (the "Plan") and vests one-third on each of the three anniversaries of the grant date.
Key Figures
Restricted shares granted: 11,149 shares
Holdings after transaction: 24,392 shares
Grant price per share: $0.00 per share
+1 more
4 metrics
Restricted shares granted
11,149 shares
Common stock award reported on August 11, 2026
Holdings after transaction
24,392 shares
Director’s direct ownership following the restricted stock grant
Grant price per share
$0.00 per share
Reported transaction price for the restricted stock award
Vesting schedule
One-third each year over 3 years
Restricted stock vests on each of the three anniversaries of grant
Key Terms
restricted stock, Amended and Restated 2007 Stock Incentive Plan, vests
3 terms
restricted stock financial
"This award of restricted stock is granted under the Company's Amended and Restated 2007 Stock Incentive Plan"
Shares granted to an individual that carry limits on transfer or sale until certain conditions are met, such as staying with the company for a set time or hitting performance targets. Think of them as a locked gift that gradually opens; for investors they matter because they affect how many shares may enter the market later, signal management incentives and potential dilution, and reveal confidence in future company performance.
Amended and Restated 2007 Stock Incentive Plan financial
"granted under the Company's Amended and Restated 2007 Stock Incentive Plan (the "Plan")"
vests financial
"and vests one-third on each of the three anniversaries of the grant date"
FAQ
What insider transaction did Monro, Inc. (MNRO) disclose for Thomas B. Okray?
Monro, Inc. reported that director Thomas B. Okray received a grant of 11,149 restricted shares of common stock on August 11, 2026, increasing his direct holdings to 24,392 shares as part of equity-based compensation.
Was the Monro, Inc. (MNRO) Form 4 transaction a purchase or a grant?
The Form 4 for Monro, Inc. shows a grant/award acquisition, not an open-market purchase. Okray received 11,149 restricted shares at a reported price of $0.00 per share under the company’s stock incentive plan.
How does the restricted stock granted to the MNRO director vest?
The restricted stock award to the Monro, Inc. director vests over three years. According to the plan terms, it vests one-third on each of the three anniversaries of the August 11, 2026 grant date, subject to the plan conditions.
Under which plan was the MNRO director’s restricted stock granted?
The restricted stock granted to the Monro, Inc. director was issued under the Amended and Restated 2007 Stock Incentive Plan. The award consists of 11,149 restricted shares that vest in three equal annual installments from the grant date.
Does the Monro, Inc. (MNRO) Form 4 indicate any Rule 10b5-1 trading plan?
No, the Form 4 for Monro, Inc. does not indicate a Rule 10b5-1 trading plan for this transaction. The filing’s 10b5-1 checkbox is unchecked, and the reported activity is a compensatory restricted stock grant, not a market trade.
AI-generated analysis. How Rhea-AI works. Not financial advice.